Training activity information
Details
Prepare a case study for haemolytic disease of the fetus and newborn which uses two or more appropriate multidisciplinary techniques
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Considering results where appropriate to:
- Inform diagnosis
- Inform further tests
- Inform treatment
- Guide transfusion support
- Guidelines and standards
- Testing algorithms
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- Which specific aspect or case of haemolytic disease of the fetus and newborn will you focus on?
- What are two or more relevant multidisciplinary techniques used in this context?
- How will you structure your case study to highlight the collaboration between the laboratory and clinical teams in managing HDFN?
- Consider the specific insights you hope to gain, such as appreciating the coordinated approach required between the laboratory and clinical teams in managing HDFN.
- Reflect on your current understanding of HDFN and how this case study preparation will enhance your knowledge and interpretive skills in this critical area of transfusion medicine.
- Discuss with your training officer potential cases of HDFN that would be suitable for this case study and the expected format and scope.
- Review the principles and applications of various laboratory techniques used in the investigation of HDFN, including maternal antibody testing, fetal blood group and antibody status, and neonatal DAT and bilirubin levels.
- Think about potential challenges, such as correlating maternal antibody titre with disease severity in the newborn or understanding the complexities of different antibody specificities, and consider how you might address them (e.g., reviewing clinical guidelines, discussing with the obstetric team).
In action
- As you develop your HDFN case study using data from different techniques (e.g., maternal serology, fetal/neonatal serology, bilirubin levels, clinical presentation), what is your rationale for selecting these specific investigations to focus on?
- How are you illustrating how these different data points contribute to the diagnosis and management of HDFN?
- What aspects of integrating maternal and neonatal laboratory findings with clinical information are straightforward, and what requires careful consideration of complex immunological interactions?
- How well do you think you are demonstrating the importance of a multidisciplinary approach in managing HDFN?
- What difficulties are you facing in combining information from different sources (e.g., laboratory, obstetrics, paediatrics)?
- What are you learning about how different disciplines contribute to the diagnosis and management of HDFN?
- How does this integrated view improve your understanding of the condition? Are there other relevant investigations or clinical details you could include?
- Do you need to seek further information from the obstetric or neonatal teams?
- Are you presenting the multidisciplinary data accurately and with appropriate clinical context?
On action
- Describe the key elements of the case study you prepared for haemolytic disease of the fetus and newborn (HDFN).
- What were the relevant maternal and fetal/neonatal clinical details and initial laboratory findings (e.g., maternal antibody screen, fetal blood group)?
- Which two or more multidisciplinary techniques did you incorporate into your case study?
- Explain why these techniques are appropriate for assessing and managing HDFN (e.g., serological investigations, molecular testing, fetal monitoring).
- What challenges did you encounter while integrating information from different laboratory disciplines (e.g., blood transfusion, molecular diagnostics) or correlating with clinical and obstetric data?
- How did preparing this case study enhance your understanding of the diagnostic and management strategies for HDFN from a multidisciplinary perspective?
- What did you learn about how different laboratory techniques, along with clinical assessments, contribute to risk stratification and intervention in HDFN?
- How did this activity improve your ability to synthesise information from various sources to build a comprehensive understanding of an HDFN case?
- How does this experience relate to the skills required for multidisciplinary team discussions involving obstetricians, neonatologists, and laboratory staff?
- What aspects of case study preparation or multidisciplinary understanding of HDFN have you identified for further development?
- How will you apply the skills gained from this activity to future case studies or discussions involving multidisciplinary approaches to HDFN?
- What specific actions will you take to improve your ability to integrate and interpret information from different disciplines involved in HDFN management?
- What resources or support would be beneficial for further developing your skills in this specialised area?
Beyond action
- Reflect on the process of preparing your case study on Haemolytic Disease of the Fetus and Newborn (HDFN), ensuring the integration of at least two multidisciplinary techniques (e.g., maternal serology, fetal monitoring, neonatal laboratory results, clinical presentation). Has your understanding of the complex interplay between maternal antibodies and fetal/neonatal red cells, and the importance of coordinated investigations across different clinical areas, deepened since you completed this training activity?
- Compare this case study preparation with other training activities involving red cell serology or case analysis. What unique challenges did you encounter in integrating information from both the mother and the baby, and in understanding the temporal sequence of diagnostic events?
- Review your initial reflections on this training activity. Have any aspects of predicting the severity of HDFN, understanding the role of different serological markers, or the clinical management of affected newborns become clearer with further learning or exposure to relevant guidelines?
- Appreciate how preparing a multidisciplinary case study enhances your understanding of the interconnectedness of different clinical and laboratory disciplines in managing complex conditions. How has this experience influenced your awareness of the importance of communication and collaboration between the laboratory, obstetrics, and neonatology in cases involving potential HDFN?
- Can you identify situations where the skills you developed during case study preparation, such as synthesising information from different sources or understanding the clinical significance of serological findings in the context of pregnancy, have been beneficial in your current work?
- What transferable skills, such as the ability to integrate laboratory findings with clinical information across different patient populations (mother and fetus/newborn), understanding the principles of complex serological investigations in a specific clinical context, effective communication with clinical colleagues, and an appreciation for the multidisciplinary approach to managing pregnancy complications, did you develop through this training activity? How will these skills be essential in your future career?
- Based on your reflection, what specific aspects of HDFN diagnosis, monitoring, and management, particularly the integration of multidisciplinary data, would you be interested in exploring further in your professional development?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Select techniques for the investigation of clinical presentations in haematology, haemostasis and transfusion science and medicine. |
| # 3 |
Outcome
Interpret the results of the laboratory investigations for cases including red and white cell disorders and haemostatic and platelet disorders, haematological malignancy and transfusion serology. |
| # 4 |
Outcome
Describe the limitations of techniques applied in the investigation of clinical presentations in haematology, haemostasis and transfusion science. |